Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 37Neoplasms 2Neoplasm Metastasis 2Venous Thromboembolism 1Recurrent Squamous Cell Lung Carcinoma 1Hormone Receptor Positive Advanced Breast Cancer 1HER2-positive Metastatic Breast Cancer 1DILI 1Cardiovascular Diseases 1Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors 1Breast Neoplasms, Male 1Breast Diseases 1

Interventions

Watchful Waiting 2Psychiatric Rehabilitation 2Immunohistochemistry 2Biopsy 2Amplified Fragment Length Polymorphism Analysis 2ribociclib 1palbociclib 1abemaciclib 1X-Ray Therapy 1Therapeutics 1Radiotherapy 1Radiosurgery 1Phlebotomy 1Mental Status and Dementia Tests 1Magnetic Resonance Spectroscopy 1Immunoenzyme Techniques 1High-Energy Shock Waves 1Gene Expression Profiling 1Fluorodeoxyglucose F18 1Blood Specimen Collection 1Biopsy, Needle 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Breast Neoplasms, Male × palbociclib × Clear all
NCT06805812 2025-02-03

PALMARES-2

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Recruiting
3,500 enrolled
Breast

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡